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Radiation Induced Optic Neuropathy: A Role for Steroids?
Kevin Leikert DO, Dan Brill MD, Poonam Bansal MD - Department of Ophthalmology
Henry Ford Health System, Detroit, Michigan

Abstract

Imaging

Introduction: Radiation induced optic neuropathy is a devastating complication of
radiotherapy to the anterior visual pathway, resulting in significant, permanent vision loss.
Presentation: A 55-year-old male presented with 5 days of decreased vision in the right eye
who had previously been treated for squamous cell carcinoma of the face. Ophthalmologic
examination and MRI showed findings consistent with radiation induced optic neuropathy.
The patient was treated with high dose IV corticosteroids followed by an oral taper.
Results: The patient’s baseline vision in the right eye was 20/20 prior the event. On the
initial presentation the patient’s visual acuity had decreased to only counting fingers in the
right eye. Immedially following the steroid treatment the patient’s visual acuity had
improved to 20/40, and two months later was measured to be 20/50.
Conclusions: High dose corticosteroids may play a role in the treatment of radiation induced
optic neuropathy.

Background
Radiation of the brain or face can have devastating effects on the eye and the optic
pathway. Radiation retinopathy is the most commonly seen complication, usually
presenting between 6 months and 3 years following radiation treatment and is commonly
monitored for in patients who have received radiation treatment in a region close to the
eyes. A less commonly seen complication which can cause severe or complete vision loss in
this patient group is radiation induced optic neuropathy (RION). It most commonly
presents 10-20 months following treatment, although cases have been documented as much
as 9 years following treatment.
Both complications have similar factors increasing the risk of occurring after treatment.
The most significant of which is the cumulative doses of radiation that exceed 50 Gy or
single doses to the anterior visual pathway of 10 Gy or more. These values vary
significantly in the literature and cases of radiation retinopathy have been documented with
as little as 15 Gy of cumulative treatment. Incrased age is also a risk factor in both diseases.
In the case of RION pre-existing compression of the optic nerve by the tumor has also been
shown to increase the risk of developing the disease.
The diagnosis of RION is based off clinical findings as well as imaging of the optic
pathway. Patients will show decreased visual acuity, visual field deficits, and decreased
color vision. MRI is the imaging modality of choice showing optic nerve enhancement on
T-1 or T-2 weighted images.
RION is thought to cause permanent vision loss with no proven beneficial treatment at this
time. Treatment with corticosteroids and anticoagulation have generally been unsuccessful
in large case series. There is some evidence of consistent improvement after early treatment
with hyperbaric oxygen, but the difficulty in obtaining this treatment has limited the
research in this area.

Case Presentation
A 55-year-old male presented with 5 days of decreased vision in the right eye. Two years
prior to presentation, he was diagnosed with squamous cell carcinoma of the skin and treated
with a cumulative radiation dose of 70 Gy. ENT and oncology were monitoring the patient
for a squamous cell carcinoma of the maxillary sinus without current treatment at that time.
On ophthalmologic exam, his baseline visual acuity of 20/20 had decreased to counting
fingers. Dilated fundus exam (Figure 1) and fluorescein angiogram (Figure 2) showed optic
disc edema and hemorrhage. MRI orbits (Figure 3) showed no interval increase in size of the
squamous cell carcinoma with slight enhancement of the optic nerve and laboratory workup
was unremarkable. The patient was diagnosed with radiation induced optic neuropathy. After
risks and benefits were discussed with the patient, he agreed to a trial of high dose steroid
therapy. The patient received three days of intravenous solumedrol (1 mg/kg/day), followed
by a twelve day taper of oral prednisone (starting at 80 mg). Ten days after steroid initiation,
the patient’s visual acuity improved to 20/40. Two months later, his visual acuity remained
improved at 20/50.

Figure 1. Fundus Photo of the right eye showing blurred disc
margins consistent with disc edema (red arrow), a disk
hemorrhage (blue arrow), and cotton wool spot consistent with
radiation retinopathy (yellow arrow)

Figure 2. Fluorescein angiogram showing hyper fluorecence
and leakage around the optic nerve consistent with disc edema
(red arrow)

Discussion

Figure 3. T2 post contrast MRI of the brain and orbits
showing slight enhancement of the optic nerve within
the optic canal (red arrow)

Conclusions

Radiation therapy is a widely utilized therapy for treatment of many cancers of the skin of
the face, the sinuses, and intracranial tumors when adequate resection is not a reasonable or
possible treatment. Guided radiotherapy can limit the radiation exposure to sensitive tissues
such as the retina and optic nerve, but radiation retinopathy and radiation induced optic
neuropathy (RION) are complications of radiation treatment that must be discussed and
monitored for following treatment. As seen with this patient, the complications may be
limited as seen with his asymptomatic radiation retinopathy, but the complications may also
be severe resulting in significantly decreased vision, as he presented with his RION,
potentially leading to complete loss of vision. These complications commonly occur within
the first two to three years as in this case, but there are documented cases of patients
presenting as much as nine years after radiation treatment, highlighting the importance of
long term ophthalmic monitoring.

• RION is a devastation complication of radiation treatment to the brain or face

Given that the rate of RION is relatively low, there is not a clear consensus at this time
regarding a definitive treatment modality. Systemic corticosteroids, intra-vitreal anti-VEGF
injections, and hyperbaric oxygen have all been trialed as potential therapies with mixed
results and no modality showing consistent benefit. Systemic corticosteroids have been
approached as a potential therapy given the success that has been seen using them as
treatment for a cerebral radiation necrosis. However, their success has been limited in the
treatment of RION and there are some small population retrospective studies showing that
patients have no signs of benefit from systemic corticosteroid treatment.

• Early intervention after presenting symptoms appears to be crucial as seen in this case
and as documented in the literature

Recently a studied was published that performed a retrospective review of 73 patients who
had received systemic corticosteroid therapy for RION. 38 of the patients had responded to
treatment with the corticosteroids and 35 of the patients showed no benefit. From this
patient data a predictive model was created which was able to obtain a high degree of
accuracy in determining which patients could benefit from treatment. Elevated BUN was
found to be significantly related to a greater response to treatment. The patient in this case
had a BUN of 21 at the time of presentation.
The current understanding of RION is limited given its relatively low prevalence. Given
that there is no clear intervention that has been show to halt or reverse the vision loss in
affected patients, further research in this area with larger prospective studies is needed.
Although some studies have dismissed systemic corticosteroids as a potential treatment for
RION, as seen with this patient there may be a subset that significantly benefit from early
treatment with high dose corticosteroids.

• Patients who have need radiation treatment to the face or brain should be warned of
ocular complications and possible decreased or loss of vision
• There is not a widely accepted treatment at this time, although systemic steroids, antiVEGF injections, and hyperbaric oxygen are all being trialed at this time
• As seen with this patient there appears to be a subset of patients that can significantly
benefit from treatment with high dose corticosteroids
• Further evaluation of recently developed predictive models may allow stratification of
patients into those that may benefit from treatment with corticosteroids

• Treatment with high dose corticosteroids should be considered in all patients presenting
with RION
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